Suppr超能文献

脓毒症中纤溶酶原激活物抑制剂-1检测的临床意义

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis.

作者信息

Iba Toshiaki, Thachil Jecko

机构信息

Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421 Japan.

Department of Haematology, Manchester Royal Infirmary, Manchester, UK.

出版信息

J Intensive Care. 2017 Sep 6;5:56. doi: 10.1186/s40560-017-0250-z. eCollection 2017.

Abstract

BACKGROUND

Disseminated thrombotic process in the microcirculation is considered to be an important cause of multiple organ dysfunction in sepsis. The fundamental purpose of this prothrombotic change was believed to be in the host defense against microbial dissemination. In that process, antifibrinolytic property plays an important role.

MAIN BODY

For the understanding of pathophysiology of sepsis, it is quite useful to grasp the alterations in coagulation/fibrinolytic parameters, i.e., plasminogen activator and plasminogen activator inhibitor-1. They play crucial roles in the development of clot formation and disseminated intravascular coagulation that leads to fatal organ dysfunction. Basically, fibrinolysis is a simple system compared to the complex coagulation cascade. Plasmin is the only factor that regulates fibrinolysis, and this enzyme is modulated by several factors including plasminogen activators and plasminogen activator inhibitor-1. However, recent studies have elucidated the complex regulation of the production, activation, and inactivation of these fibrinolytic factors.

CONCLUSION

The dynamic change of the fibrinolytic system plays a crucial role in the pathophysiology of sepsis. In this commentary, we introduce the recent advances of the research regarding fibrinolytic system.

摘要

背景

微循环中的弥散性血栓形成过程被认为是脓毒症中多器官功能障碍的重要原因。这种促血栓形成变化的根本目的被认为是宿主抵御微生物播散。在此过程中,抗纤溶特性发挥着重要作用。

正文

为了理解脓毒症的病理生理学,掌握凝血/纤溶参数的变化,即纤溶酶原激活物和纤溶酶原激活物抑制剂-1,是非常有用的。它们在导致致命器官功能障碍的血栓形成和弥散性血管内凝血的发展中起着关键作用。基本上,与复杂的凝血级联反应相比,纤溶是一个简单的系统。纤溶酶是调节纤溶的唯一因素,该酶受包括纤溶酶原激活物和纤溶酶原激活物抑制剂-1在内的多种因素调节。然而,最近的研究阐明了这些纤溶因子的产生、激活和失活的复杂调节机制。

结论

纤溶系统的动态变化在脓毒症的病理生理学中起着关键作用。在本述评中,我们介绍了纤溶系统研究的最新进展。

相似文献

1
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis.
J Intensive Care. 2017 Sep 6;5:56. doi: 10.1186/s40560-017-0250-z. eCollection 2017.
3
Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC.
J Intensive Care. 2015 Feb 19;3:8. doi: 10.1186/s40560-015-0075-6. eCollection 2015.
9
Posttrauma coagulation and fibrinolysis.
Crit Care Med. 1992 May;20(5):594-600. doi: 10.1097/00003246-199205000-00009.
10
Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Blood Coagul Fibrinolysis. 1994 Oct;5(5):829-32. doi: 10.1097/00001721-199410000-00022.

引用本文的文献

2
PAI-1 as a critical factor in the resolution of sepsis and acute kidney injury in old age.
Front Cell Dev Biol. 2024 Jan 18;11:1330433. doi: 10.3389/fcell.2023.1330433. eCollection 2023.
4
Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries.
Biomedicines. 2022 Jan 25;10(2):264. doi: 10.3390/biomedicines10020264.
6
Disseminated intravascular coagulation and its immune mechanisms.
Blood. 2022 Mar 31;139(13):1973-1986. doi: 10.1182/blood.2020007208.
7
Visceral fat-specific regulation of plasminogen activator inhibitor-1 in aged septic mice.
J Cell Physiol. 2022 Jan;237(1):706-719. doi: 10.1002/jcp.30551. Epub 2021 Aug 9.
9
UEG Week 2019 Poster Presentations.
United European Gastroenterol J. 2019 Oct;7(8_suppl):189-1030. doi: 10.1177/2050640619854671.

本文引用的文献

1
Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis.
J Intensive Care. 2017 Jul 11;5:42. doi: 10.1186/s40560-017-0238-8. eCollection 2017.
4
Role of fibrinolysis in sepsis.
Semin Thromb Hemost. 2013 Jun;39(4):392-9. doi: 10.1055/s-0033-1334140. Epub 2013 Feb 27.
5
Thrombosis as an intravascular effector of innate immunity.
Nat Rev Immunol. 2013 Jan;13(1):34-45. doi: 10.1038/nri3345. Epub 2012 Dec 7.
6
Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin.
Thromb Res. 2008;122(2):271-81. doi: 10.1016/j.thromres.2008.04.008.
8
Fibrinolysis and host response in bacterial infections.
Thromb Haemost. 2007 Sep;98(3):512-20.
9
TAFI and PAI-1 levels in human sepsis.
Thromb Res. 2006;118(2):205-12. doi: 10.1016/j.thromres.2005.06.007. Epub 2005 Jul 11.
10
Pleiotropic functions of plasminogen activator inhibitor-1.
J Thromb Haemost. 2005 Jan;3(1):35-45. doi: 10.1111/j.1538-7836.2004.00827.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验